HALEON Stock Overview
Engages in the research and development, manufacture, marketing, and sale of consumer healthcare products in Pakistan, Africa, Australia, North America, Asia, the Middle East, and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for HALEON from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Haleon Pakistan Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨800.85 |
| 52 Week High | PK₨975.00 |
| 52 Week Low | PK₨180.00 |
| Beta | 0.59 |
| 1 Month Change | -5.00% |
| 3 Month Change | -7.79% |
| 1 Year Change | 277.51% |
| 3 Year Change | 219.27% |
| 5 Year Change | 263.05% |
| Change since IPO | 1,131.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| HALEON | PK Personal Products | PK Market | |
|---|---|---|---|
| 7D | 0.5% | -1.1% | 1.0% |
| 1Y | 277.5% | -6.7% | 52.9% |
Return vs Industry: HALEON exceeded the PK Personal Products industry which returned -6.2% over the past year.
Return vs Market: HALEON exceeded the PK Market which returned 56% over the past year.
Price Volatility
| HALEON volatility | |
|---|---|
| HALEON Average Weekly Movement | 5.5% |
| Personal Products Industry Average Movement | 5.1% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in PK Market | 9.8% |
| 10% least volatile stocks in PK Market | 4.1% |
Stable Share Price: HALEON has not had significant price volatility in the past 3 months compared to the PK market.
Volatility Over Time: HALEON's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 481 | Farhan Haroon | www.haleon.pk |
Haleon Pakistan Limited engages in the research and development, manufacture, marketing, and sale of consumer healthcare products in Pakistan, Africa, Australia, North America, Asia, the Middle East, and Europe. It offers oral health, pain relief, vitamins and mineral supplements, and respiratory health products. The company sells its products under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, Actified, T-Day, ENO, Herbactive, Hydrozole, Qalsium-D, and Voltral Emulgel brands.
Haleon Pakistan Limited Fundamentals Summary
| HALEON fundamental statistics | |
|---|---|
| Market cap | PK₨93.74b |
| Earnings (TTM) | PK₨4.58b |
| Revenue (TTM) | PK₨37.21b |
20.5x
P/E Ratio2.5x
P/S RatioIs HALEON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HALEON income statement (TTM) | |
|---|---|
| Revenue | PK₨37.21b |
| Cost of Revenue | PK₨24.39b |
| Gross Profit | PK₨12.82b |
| Other Expenses | PK₨8.24b |
| Earnings | PK₨4.58b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 39.11 |
| Gross Margin | 34.45% |
| Net Profit Margin | 12.31% |
| Debt/Equity Ratio | 5.2% |
How did HALEON perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield51%
Payout RatioDoes HALEON pay a reliable dividends?
See HALEON dividend history and benchmarks| Haleon Pakistan dividend dates | |
|---|---|
| Ex Dividend Date | Mar 11 2025 |
| Dividend Pay Date | Apr 15 2025 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 52 days |
Does HALEON pay a reliable dividends?
See HALEON dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/21 06:48 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Haleon Pakistan Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arvind Anand | Fortune Securities Limited |
| Abdulkader Puranwala | ICICI Securities Ltd. |